Trials / Completed
CompletedNCT01742234
RELIVE Informed Consent Study
Renal and Lung Living Donors Evaluation (RELIVE) Informed Consent Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 624 (actual)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
An organ transplant is frequently the best option and, in some cases, the only option to save the lives of transplant recipients. Receiving an organ from a living donor eliminates the need to wait for a deceased donor, an option that many transplant recipients do not survive. However, donating an organ presents health concerns to the donor as well. This study will use surveys to evaluate the understanding of risk and psychological pressure that living organ donors felt when making the decision to donate. It will also compare participants' answers across geographic, racial and socio-economic backgrounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Organ Donation | People in this study will donate either a lung or kidney |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2012-12-05
- Last updated
- 2017-03-27
Source: ClinicalTrials.gov record NCT01742234. Inclusion in this directory is not an endorsement.